Name: UMIN ID:
Unique ID issued by UMIN | UMIN000031221 |
---|---|
Receipt number | R000035488 |
Scientific Title | A multicenter phase II study of eribulin monotherapy in patients with BRAF V600E mutant metastatic colorectal cancer |
Date of disclosure of the study information | 2018/03/26 |
Last modified on | 2021/09/24 09:34:44 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/02/09 12:11:08 | ||
2 | Update | 2018/05/02 15:21:11 | Recruitment status |
|
3 | Update | 2018/05/02 15:22:22 | Institutions |
|
4 | Update | 2018/07/05 14:11:37 | Organization Organization Division name Division name Address Address TEL |
|
5 | Update | 2018/10/05 11:02:52 | Institutions |
|
6 | Update | 2019/02/14 09:56:05 | Institutions |
|
7 | Update | 2019/08/16 08:57:10 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
8 | Update | 2019/08/16 08:58:55 | Date of IRB Last follow-up date |
|
9 | Update | 2019/10/15 08:45:17 | Recruitment status |
|
10 | Update | 2019/11/11 10:42:47 | Recruitment status |
|
11 | Update | 2020/08/17 11:42:47 | Number of participants that the trial has enrolled |
|
12 | Update | 2020/08/17 11:43:17 | Last follow-up date |
|
13 | Update | 2020/08/17 11:44:14 | Organization Institutions |
|
14 | Update | 2021/05/12 10:55:04 | Organization Organization Division name Division name Zip code Address Address TEL Name of primary person or sponsor Institute Institute |
|
15 | Update | 2021/09/24 09:34:44 | Recruitment status |